Skip to Main Content

Author Details

Simon A Gayther
Cedars-Sinai Medical Center
1993
284
72
PMIDPaper TitleJournal TitlePublished Year
36368129Profiling the immune landscape in mucinous ovarian carcinoma.Gynecol Oncol2023
38014246<i>Cis</i>- and <i>trans</i>-eQTL TWAS of breast and ovarian cancer identify more than 100 risk associated genes in the BCAC and OCAC consortia.bioRxiv2023
37857693Author Correction: A biallelic multiple nucleotide length polymorphism explains functional causality at 5p15.33 prostate cancer risk locus.Nat Commun2023
37612286A biallelic multiple nucleotide length polymorphism explains functional causality at 5p15.33 prostate cancer risk locus.Nat Commun2023
36948887p53 and ovarian carcinoma survival: an Ovarian Tumor Tissue Analysis consortium study.J Pathol Clin Res2023
37409955Predicted Proteome Association Studies of Breast, Prostate, Ovarian, and Endometrial Cancers Implicate Plasma Protein Regulation in Cancer Susceptibility.Cancer Epidemiol Biomarkers Prev2023
36688720Lifetime ovulatory years and risk of epithelial ovarian cancer: a multinational pooled analysis.J Natl Cancer Inst2023
36572991CCNE1 and survival of patients with tubo-ovarian high-grade serous carcinoma: An Ovarian Tumor Tissue Analysis consortium study.Cancer2023
34844974Comprehensive epithelial tubo-ovarian cancer risk prediction model incorporating genetic and epidemiological risk factors.J Med Genet2022
35492879A multi-level investigation of the genetic relationship between endometriosis and ovarian cancer histotypes.Cell Rep Med2022
35816189Molecular Subclasses of Clear Cell Ovarian Carcinoma and Their Impact on Disease Behavior and Outcomes.Clin Cancer Res2022
36210504Copy Number Variants Are Ovarian Cancer Risk Alleles at Known and Novel Risk Loci.J Natl Cancer Inst2022
35883104DNA methylation and transcriptomic features are preserved throughout disease recurrence and chemoresistance in high grade serous ovarian cancers.J Exp Clin Cancer Res2022
34965383Functional analysis of the 1p34.3 risk locus implicates GNL2 in high-grade serous ovarian cancer.Am J Hum Genet2022
34897700Validated biomarker assays confirm that ARID1A loss is confounded with MMR deficiency, CD8<sup>+</sup> TIL infiltration, and provides no independent prognostic value in endometriosis-associated ovarian carcinomas.J Pathol2022
34782936MCM3 is a novel proliferation marker associated with longer survival for patients with tubo-ovarian high-grade serous carcinoma.Virchows Arch2022
32546565Population-based targeted sequencing of 54 candidate genes identifies <i>PALB2</i> as a susceptibility gene for high-grade serous ovarian cancer.J Med Genet2021
33852846Single-cell transcriptomics identifies gene expression networks driving differentiation and tumorigenesis in the human fallopian tube.Cell Rep2021
34965417Human iPSC-derived fallopian tube organoids with BRCA1 mutation recapitulate early-stage carcinogenesis.Cell Rep2021
34439109Risks and Function of Breast Cancer Susceptibility Alleles.Cancers (Basel)2021
33990587Author Correction: A case-only study to identify genetic modifiers of breast cancer risk for BRCA1/BRCA2 mutation carriers.Nat Commun2021
31409603Master transcription factors form interconnected circuitry and orchestrate transcriptional networks in oesophageal adenocarcinoma.Gut2020
32107557Ovarian and Breast Cancer Risks Associated With Pathogenic Variants in RAD51C and RAD51D.J Natl Cancer Inst2020
33086730Rare Germline Genetic Variants and the Risks of Epithelial Ovarian Cancer.Cancers (Basel)2020
32946763Ovarian Cancer Risk Variants Are Enriched in Histotype-Specific Enhancers and Disrupt Transcription Factor Binding Sites.Am J Hum Genet2020
32690948Prostate cancer reactivates developmental epigenomic programs during metastatic progression.Nat Genet2020
32959149Offspring sex and risk of epithelial ovarian cancer: a multinational pooled analysis of 12 case-control studies.Eur J Epidemiol2020
32620889Assessment of polygenic architecture and risk prediction based on common variants across fourteen cancers.Nat Commun2020
32641237Menopausal hormone therapy prior to the diagnosis of ovarian cancer is associated with improved survival.Gynecol Oncol2020
32555365Clinical and pathological associations of PTEN expression in ovarian cancer: a multicentre study from the Ovarian Tumour Tissue Analysis Consortium.Br J Cancer2020
32554541Development and Validation of the Gene Expression Predictor of High-grade Serous Ovarian Carcinoma Molecular SubTYPE (PrOTYPE).Clin Cancer Res2020
32473302Prognostic gene expression signature for high-grade serous ovarian cancer.Ann Oncol2020
32332753Non-coding somatic mutations converge on the PAX8 pathway in ovarian cancer.Nat Commun2020
31469419Identification of novel epithelial ovarian cancer loci in women of African ancestry.Int J Cancer2020
30487138Functional Analysis and Fine Mapping of the 9p22.2 Ovarian Cancer Susceptibility Locus.Cancer Res2019
31825847A Study of High-Grade Serous Ovarian Cancer Origins Implicates the SOX18 Transcription Factor in Tumor Development.Cell Rep2019
31239549A combination of the immunohistochemical markers CK7 and SATB2 is highly sensitive and specific for distinguishing primary ovarian mucinous tumors from colorectal and appendiceal metastases.Mod Pathol2019
31548585Publisher Correction: Shared heritability and functional enrichment across six solid cancers.Nat Commun2019
31307004Super-Enhancer-Associated LncRNA UCA1 Interacts Directly with AMOT to Activate YAP Target Genes in Epithelial Ovarian Cancer.iScience2019
31619158GENAVi: a shiny web application for gene expression normalization, analysis and visualization.BMC Genomics2019
30898391Genome-wide association studies identify susceptibility loci for epithelial ovarian cancer in east Asian women.Gynecol Oncol2019
31043753A transcriptome-wide association study of high-grade serous epithelial ovarian cancer identifies new susceptibility genes and splice variants.Nat Genet2019
31001917Evaluation of vitamin D biosynthesis and pathway target genes reveals UGT2A1/2 and EGFR polymorphisms associated with epithelial ovarian cancer in African American Women.Cancer Med2019
30499236A comprehensive gene-environment interaction analysis in Ovarian Cancer using genome-wide significant common variants.Int J Cancer2019
30683880Shared heritability and functional enrichment across six solid cancers.Nat Commun2019
30576442Molecular signatures of X chromosome inactivation and associations with clinical outcomes in epithelial ovarian cancer.Hum Mol Genet2019
28633381Robust Tests for Additive Gene-Environment Interaction in Case-Control Studies Using Gene-Environment Independence.Am J Epidemiol2018
30134598rs495139 in the TYMS-ENOSF1 Region and Risk of Ovarian Carcinoma of Mucinous Histology.Int J Mol Sci2018
30054336A Transcriptome-Wide Association Study Among 97,898 Women to Identify Candidate Susceptibility Genes for Epithelial Ovarian Cancer Risk.Cancer Res2018
29967001Transcriptomic Characterization of Endometrioid, Clear Cell, and High-Grade Serous Epithelial Ovarian Carcinoma.Cancer Epidemiol Biomarkers Prev2018
  • 1 - 50 of 284

Recommended Authors

Pier Selenica
Memorial Sloan Kettering Cancer Center
Career Start Year 2017
Number of shared co-authors 12
Arnaud Da Cruz Paula
Memorial Sloan Kettering Cancer Center
Career Start Year 2014
Number of shared co-authors 6
Salvatore Piscuoglio
University of Basel
Career Start Year 2008
Number of shared co-authors 8
Susanna L Cooke
Institute of Cancer Sciences, University of Glasgow
Career Start Year 2006
Number of shared co-authors 31
Nicola Waddell
QIMR Berghofer Medical Research Institute
Career Start Year 2006
Number of shared co-authors 66
Kasmintan A Schrader
University of British Columbia
Career Start Year 2005
Number of shared co-authors 45
Laurie Burdett
National Cancer Institute, Frederick National Laboratory for Cancer Research
Career Start Year 2005
Number of shared co-authors 38
Liying Zhang
The Fifth Affiliated Hospital, Sun Yat-sen University
Career Start Year 2004
Number of shared co-authors 40
Dariush Etemadmoghadam
Peter MacCallum Cancer Centre
Career Start Year 2004
Number of shared co-authors 35
Siddhartha Deb
Olivia Newton-John Cancer Research Institute
Career Start Year 2002
Number of shared co-authors 3
Colin C Pritchard
University of Washington, USA Brotman Baty Institute for Precision Medicine
Career Start Year 1999
Number of shared co-authors 20
Tobias Sj??blom
Uppsala University
Career Start Year 1999
Number of shared co-authors 1
Dirce Maria Carraro
AC Camargo Cancer Center
Career Start Year 1998
Number of shared co-authors 9
Ingrid Hedenfalk
Lund University and Skane University Hospital
Career Start Year 1997
Number of shared co-authors 13
Karen J Taylor
University of Edinburgh
Career Start Year 1996
Number of shared co-authors 4
Marbin Pineda
Center for Cancer Research, National Cancer Institute
Career Start Year 1995
Number of shared co-authors 29
Curtis Gumbs
The University of Texas MD Anderson Cancer Center
Career Start Year 1995
Number of shared co-authors 8
Simone Maistro
Instituto do Cancer do Estado de Sao Paulo, Universidade de Sao Paulo
Career Start Year 1994
Number of shared co-authors 0
Samuel Aparicio
University of British Columbia
Career Start Year 1993
Number of shared co-authors 41
Phillip A Futreal
The University of Texas MD Anderson Cancer Center
Career Start Year 1991
Number of shared co-authors 58
Ben Ho Park
Vanderbilt University Medical Center
Career Start Year 1990
Number of shared co-authors 9
Lora H Ellenson
Memorial Sloan Kettering Cancer Center
Career Start Year 1989
Number of shared co-authors 8
James M Ford
Stanford University
Career Start Year 1989
Number of shared co-authors 20
Ming K Lee
University of Washington
Career Start Year 1988
Number of shared co-authors 8
Bharati Bapat
Mt Sinai Hospital
Career Start Year 1988
Number of shared co-authors 19
Olli Kallioniemi
Karolinska Institute
Career Start Year 1984
Number of shared co-authors 27
Andrew D Cherniack
Dana-Farber Cancer Institute
Career Start Year 1984
Number of shared co-authors 19
Edison T Liu
USA The Jackson Laboratory Cancer Center
Career Start Year 1982
Number of shared co-authors 7
Heather Thorne
Peter MacCallum Cancer Centre
Career Start Year 1982
Number of shared co-authors 95
Mary-Claire King
University of Washington
Career Start Year 1975
Number of shared co-authors 27

Collaborators

Susan J Ramus
School of Clinical Medicine, University of NSW Sydney, Lowy Cancer Research Centre
Co-authored papers 165
Paul D P Pharoah
Center for Cancer Genetic Epidemiology, University of Cambridge
Co-authored papers 157
Ellen L Goode
Mayo Clinic College of Medicine
Co-authored papers 119
Usha Menon
College of Nursing, University of South Florida
Co-authored papers 108
Honglin Song
University of Cambridge
Co-authored papers 102
Joellen M Schildkraut
Rollins School of Public Health, Emory University
Co-authored papers 101
Aleksandra Gentry-Maharaj
UCL EGA Institute for Women's Health, University College London
Co-authored papers 100
Andrew Berchuck
Duke School of Medicine
Co-authored papers 98
Alice S Whittemore
Co-authored papers 92
Georgia Chenevix-Trench
QIMR Berghofer Medical Research Institute
Co-authored papers 91
Celeste Leigh Pearce
University of Michigan School of Public Health ann arbor
Co-authored papers 90
Marc T Goodman
Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center
Co-authored papers 89
Anna H Wu
University of Southern California
Co-authored papers 87
Jenny Chang-Claude
German Cancer Research Center (DKFZ)
Co-authored papers 82
Douglas F Easton
University of Cambridge
Co-authored papers 82
Jennifer A Doherty
Huntsman Cancer Institute, University of Utah
Co-authored papers 80
Beth Y Karlan
David Geffen School of Medicine, University of California los angeles
Co-authored papers 79
Mary Anne Rossing
Fred Hutchinson Cancer Research Center
Co-authored papers 77
Brooke L Fridley
H. Lee Moffitt Cancer Center and Research Institute
Co-authored papers 76
Hoda Anton-Culver
University of California irvine
Co-authored papers 72
Jonathan Tyrer
Co-authored papers 70
Jacek Gronwald
International Hereditary Cancer Center, Pomeranian Medical University
Co-authored papers 66
Malcolm C Pike
Memorial Sloan-Kettering Cancer Center
Co-authored papers 64
Weiva Sieh
Co-authored papers 63
Peter A Fasching
Otto-Friedrich-University Bamberg
Co-authored papers 62
Nicolas Wentzensen
National Cancer Institute, National Institutes of Health
Co-authored papers 60
Jan Lubinski
Pomeranian Medical University
Co-authored papers 60
Elisa V Bandera
Co-authored papers 56
Diether Lambrechts
Co-authored papers 55
Lambertus A Kiemeney
Co-authored papers 49
Release 1.2